This paper is a study that reveals how the amygdala-hypothalamus-liver axis rapidly induces metabolic changes during acute stress situations. It demonstrates that a new neural circuit, separate from the classical stress systems (HPA axis, adrenal medulla), regulates important physiological changes such as blood glucose elevation and appetite suppression during stress. When exposed to repeated stress, the function of this pathway deteriorates, suggesting a potential link to metabolic diseases such as type 2 diabetes.


1. Stress and Energy Mobilization: Existing Knowledge

When animals face threats or stressful situations, the body rapidly mobilizes energy stores to secure the stamina needed for defensive behaviors such as fleeing (flight) or freezing. During this process, cardiovascular and musculoskeletal responses are activated, and changes in glucose metabolism also occur. For example,

"The glycemic response to stress is closely associated with 'fight-or-flight' behavior."

Such blood glucose elevation (hyperglycemia) also enhances memory and situational judgment, helping to rapidly analyze threats. Meanwhile, behaviors that compete with defense, such as feeding and exploration, are suppressed. This metabolic emergency adaptability has been evolutionarily conserved, and despite its importance, our understanding of the brain circuits that orchestrate these responses remains insufficient.


2. Discovery of a New Amygdala-Liver Neural Circuit

The research team identified a new 'amygdala-hypothalamus-liver (AMG-VMH-Liver)' axis. This axis rapidly elevates blood glucose and suppresses appetite during stress situations, independently of the existing HPA axis and adrenal medulla. They found that repeated stress impairs the function of this circuit, linking it to metabolic abnormalities such as type 2 diabetes.


3. Stress-Induced Metabolic Changes

When C57Bl/6 mice were exposed to 'acute restraint stress' and 'social stress (the scent of a cage occupied by another male)', immediate blood glucose elevation and appetite suppression were observed.

  • During this process, corticosterone, adrenaline, and glucagon levels increased, but insulin and noradrenaline showed no change.
  • Stress was also confirmed to increase the expression of the hepatic glucose production gene (G6pc).
  • Even very brief stress of just 5 minutes rapidly elevated blood glucose and stress hormones.

"Restraint stress rapidly elevated blood glucose and decreased appetite."

Stress and blood glucose changes - Figure 1


4. Activation and Function of Amygdala (MeA) Neurons

  • Stress triggered activation of amygdala (MeA) neurons.
  • Real-time calcium imaging showed that MeA neurons were sharply activated at the moment of 'capture' before the threat situation began.
  • This activation preceded the increase in blood glucose.
  • When MeA neurons were artificially excited using DREADD (chemogenetic) techniques:
    • Blood glucose rose even without stress
    • It was confirmed that blood glucose could be elevated without hormones from the existing stress axes (HPA, adrenal medulla)

"Activation of the amygdala (MeA) alone was sufficient to raise blood glucose without any hormonal changes."

This effect also induced appetite suppression and was not directly related to anxiety or fear-related behaviors.


5. Detailed Circuits: MeA to VMH and MeA to BNST

MeA neuron projections and activation - Figure 2

  • Neural bundles extend from the MeA to the ventromedial hypothalamus (VMH) and BNST respectively.
  • During stress situations, specifically only MeA to VMH neurons were actively engaged in blood glucose elevation.
  • The MeA to BNST circuit has other stress-related roles but minimal involvement in blood glucose regulation.

"Acute stress primarily activates MeA to VMH neurons."


6. Diverse Neuronal Populations and Functional Genes

Types and genes of MeA-VMH projection neurons - Figure 3

  • The MeA to VMH pathway includes both glutamatergic (excitatory) and GABAergic (inhibitory) neurons.
  • These neurons show differences in the expression of genes (such as G6pc) associated with hepatic signal regulation.
  • At the genetic level, there are also associations with blood glucose, body weight, and diabetes-related changes in humans.

"Both excitatory and inhibitory neurons in the MeA to VMH pathway contribute to blood glucose elevation."


7. Direct Hepatic Regulation Mechanism of the MeA-VMH Circuit

MeA-liver multi-synaptic neural connections - Figure 4

  • Blocking MeA to VMH neurons prevented the hyperglycemic response during stress.
  • Conversely, activating these neurons raised blood glucose, and this effect was independent of 'classical hormones' such as insulin, glucagon, and corticosterone.
  • Neural pathways extend to the liver, and it was confirmed that sympathetic nerves from the VMH to the periphery promote hepatic glucose production (gluconeogenesis).
    • Multi-synaptic neural connections were directly revealed through PRV-GFP virus and Cre-tracing.
  • When this circuit was artificially stimulated, gluconeogenesis-related genes and metabolic processes in the liver were rapidly activated.
  • This neural circuit creates the flow of increased hepatic glucose production -> blood glucose elevation -> support for defensive behavior.

"The amygdala-hypothalamus-liver circuit increases hepatic glucose production to support stress coping."


8. Circuit Desensitization from Repeated Stress and Metabolic Disease Risk

Circuit response decline from repeated stress - Figure 5

  • When stress is repeated multiple times (e.g., repeated restraint or social stress):
    • Initially, blood glucose and neuronal activation increased significantly, but with repeated exposure, neuronal activation and glycemic responses gradually declined (desensitization)
  • When MeA to VMH neurons were experimentally depleted:
    • Stress-induced blood glucose elevation was reduced
    • Under metabolic stress such as a high-fat diet, glycemic control worsened, weight gain increased, and hepatic metabolic gene expression abnormalities became more severe
  • In other words, chronic stress or impairment of this circuit is directly linked to increased risk of metabolic diseases (obesity, type 2 diabetes, etc.).

"After habituation to repeated stress, functional desensitization of this circuit causes metabolic disorders and weight gain."


9. Conclusion: Stress and Metabolic Disease Linkage Through the Brain-Liver Circuit

This study is significant in revealing the amygdala-hypothalamus-liver circuit as a neural pathway that orchestrates metabolism (particularly blood glucose regulation) in the acute stress response, independently of classical hormonal axes. Repeated desensitization of this circuit can lead to persistent hyperglycemia and worsening metabolic disease, suggesting that stress management is also important from the perspective of metabolic disease prevention.

"If such mechanisms also operate in humans, amygdala signaling abnormalities in individuals chronically exposed to stress could lead to increased metabolic disease risk."


Closing

This paper offers a new explanation from the perspective of brain-liver neural circuits for why blood glucose rises when we are stressed and why chronic stress can increase the risk of diseases such as diabetes and obesity. It provides important clues for understanding the brain-body-metabolism connection and emphasizes the need for an integrated approach to stress management and metabolic disease prevention.

Related writing